文献速递其他结缔组织病

肌炎及其他神经肌肉疾病患者肌肉活检中MHC I类分子表达模式分析

The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

对约翰霍普金斯神经肌肉病理实验室2013年8月至2017年1月间357例诊断性肌肉活检行MHC-I免疫染色,比较组织学正常、特发性炎性肌病、非炎性肌病和神经源性疾病的染色阳性率与模式。MHC-I异常染色诊断IIMs的敏感性为0.95、特异性为0.82;血管周MHC-I染色模式仅见于皮肌炎,包括一半无血管周萎缩的皮肌炎活检。

要点

  • MHC-I异常染色在皮肌炎98%、散发性包涵体肌炎100%、免疫介导坏死性肌病100%和 polymyositis 77%中可见。
  • 非炎性肌病MHC-I异常染色阳性率32%,神经源性疾病30%。
  • 血管周MHC-I染色模式仅见于皮肌炎,18例无血管周萎缩的皮肌炎活检中50%有此模式。

核心结论

  • MHC-I免疫染色有助于区分特发性炎性肌病与非炎性肌病或神经源性疾病。

研究设计与样本

  • 回顾性分析2013年8月至2017年1月约翰霍普金斯神经肌肉病理实验室处理的357例诊断性肌肉活检,均行MHC-I免疫染色。

主要发现

  • MHC-I异常染色在皮肌炎为98%、散发性包涵体肌炎为100%、免疫介导坏死性肌病为100%、polymyositis为77%。
  • MHC-I异常染色在非炎性肌病为32%、神经源性疾病为30%。
  • MHC-I异常染色诊断特发性炎性肌病的敏感性为0.95、特异性为0.82。
  • 灶性MHC-I染色模式与免疫介导坏死性肌病相关,弥漫性模式在散发性包涵体肌炎更常见,血管周模式在皮肌炎显著更常见。
  • 18例无血管周萎缩的皮肌炎活检中50%存在血管周MHC-I染色模式。

关键数值与推荐

  • MHC-I异常染色诊断特发性炎性肌病的敏感性为0.95、特异性为0.82。
  • 血管周MHC-I染色模式仅见于皮肌炎,包括50%无血管周萎缩的皮肌炎活检。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Diagnostic muscle biopsies are routinely immunostained for major histocompatibility complex class I (MHC-I) protein. In this study we analysed the prevalence and patterns of MHC-I immunostaining in biopsies from patients with different types of myopathies and neurogenic disorders. METHODS: All 357 diagnostic muscle biopsies processed at the Johns Hopkins Neuromuscular Pathology Laboratory from August 2013 to January 2017 were immunostained for MHC-I. The prevalence and patterns of MHC-I immunostaining were compared between patients with histologically normal muscle biopsies (n = 31), idiopathic inflammatory myopathies (IIMs; n = 170), non-inflammatory myopathies (n = 60) and neurogenic disorders (n = 96). RESULTS: MHC-I immunostaining was abnormal in most patients with DM (98%), sporadic IBM (sIBM; 100%), immune-mediated necrotizing myopathy (IMNM; 100%) and polymyositis (77%). In contrast, MHC-I immunostaining was less frequently present in non-inflammatory myopathies (32%) or neurogenic disorders (30%). Overall, abnormal MHC-I immunostaining had a sensitivity of 0.95 and a specificity of 0.82 for diagnosing IIMs. A focal MHC-I staining pattern was associated with IMNM, whereas a global pattern was more prevalent in sIBM and a perifascicular pattern was significantly more common in dermatomyositis. Among 18 DM biopsies without perifascicular atrophy, 50% had a perifascicular MHC-I staining pattern. Sarcoplasmic upregulation staining was more common than sarcolemmal staining across all groups. CONCLUSION: MHC-I immunostaining was useful to distinguish IIMs from non-inflammatory myopathies or neurogenic disorders. Of note, a perifascicular MHC-I staining pattern was present only in those with DM, including half of those without perifascicular atrophy; many of these biopsies may not otherwise have been diagnostic for DM.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Milisenda JC, Pinal-Fernandez I, Lloyd TE, et al. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders. Rheumatology (Oxford). 2023. PMID: 36707996. doi:10.1093/rheumatology/kead052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。